Ken Griffin’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,138
| Closed | -$45.1K | – | 6270 |
|
|
2025
Q1 | $45.1K | Buy |
+20,138
| New | +$45.1K | ﹤0.01% | 5389 |
|
|
2024
Q1 | – | Sell |
-1,927
| Closed | -$14.7K | – | 6392 |
|
|
2023
Q4 | $14.7K | Buy |
+1,927
| New | +$14.7K | ﹤0.01% | 5452 |
|
|
2023
Q2 | – | Sell |
-1,239
| Closed | -$20.5K | – | 6059 |
|
|
2023
Q1 | $20.5K | Buy |
+1,239
| New | +$20.5K | ﹤0.01% | 5390 |
|
|
2022
Q3 | – | Sell |
-2,033
| Closed | -$182K | – | 6207 |
|
|
2022
Q2 | $182K | Buy |
2,033
+466
| +30% | +$41.7K | ﹤0.01% | 5042 |
|
|
2022
Q1 | $135K | Buy |
1,567
+1,186
| +311% | +$102K | ﹤0.01% | 5504 |
|
|
2021
Q4 | $35K | Sell |
381
-90
| -19% | -$8.27K | ﹤0.01% | 6235 |
|
|
2021
Q3 | $95K | Sell |
471
-16,531
| -97% | -$3.33M | ﹤0.01% | 5907 |
|
|
2021
Q2 | $7.91M | Buy |
+17,002
| New | +$7.91M | ﹤0.01% | 1665 |
|